Sotatercept PAH: Long-Term Safety & Mortality Benefit

“`html BREAKING: sotatercept Cuts PAH Mortality Risk BREAKING: Sotatercept Cuts PAH Mortality Risk By Amelia Stone | SAN FRANCISCO – 2025/05/30 15:46:49 sotatercept (Winrevair; Merck) is demonstrating a… The post Sotatercept PAH: Long-Term Safety & Mortality Benefit appeared first on NewsyList. Source link

Lessons in Progressive Pulmonary Fibrosis Treatment

Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates Personalized Approaches to Progressive pulmonary fibrosis Treatment: A New Era Personalized Approaches to Progressive Pulmonary Fibrosis Treatment: A New Era Imagine a world where the debilitating effects of *progressive pulmonary fibrosis* (PPF) are not a life sentence, but a manageable condition.this isn’t science fiction; … Read more

Sleep Patterns, Predictors, and Pharmacologic Interventions in the ICU

Many patients in the intensive care unit (ICU) struggle with sleep disturbance, but researchers are still learning how poor sleep affects recovery and outcomes. At the American Thoracic Society (ATS) 2025 International Conference, 3 posters looked at different aspects of sleep in patients who are critically ill, from how well sleep medications like temazepam work … Read more